🇺🇸 FDA
Patent

US 12186313

Pyridazinone compounds and their use as DAAO inhibitors

granted A61KA61K31/50A61K31/501

Quick answer

US patent 12186313 (Pyridazinone compounds and their use as DAAO inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/50, A61K31/501, A61K45/06, A61P